Bovitect PI 100ml

R1 446,00 excl.

This modified live vaccine reduces the incidence of morbidity and mortality caused by Mannheimia haemolytica and BHV-1 (IBR).

Category:

Description

FOR ANIMAL USE ONLY

BOVI-TECT PI

Reg. No. G3001 (Act 36/1947)

Namibia Reg. No. V02/24.4/786 [NS0]

INDICATIONS

The combination vaccine reduces the incidence of morbidity and mortality caused by undifferentiated bovine respiratory diseases (pasteurellosis) associated with M. (Pasteurella) haemolytica and BHV 1 (infectious bovine rhinotracheitis – IBR).

This vaccine is also recommended for inclusion in a vaccination programme for feedlot cattle at processing.

COMPOSITION

Mannheimia (Pasteurella) haemolytica biotype A serotype 1/17 cell-free supernatant leukotoxin vaccine for cattle, to be used in conjunction with modified live bovine herpes virus 1 (BHV 1), supplied in a smaller vial labeled Bovi-Tect PI IBR component.

For optimal use, consult your veterinarian.